Trial intelligence / Profile preview

Human fibrinogen for congenital fibrinogen deficiency

CTR20130449Phase 3Completed

Sponsor
Shanxi Kangbao Biological Products
Start
Dec 2016
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of Fibrinogen human in fibrinogen deficiency, congenital hypofibrinogenemia, sponsored by Shanxi Kangbao Biological Products. Started Dec 2016; status: completed.

02

Drugs

Fibrinogen human
03

Conditions

fibrinogen deficiencycongenital hypofibrinogenemia

Beyond the preview

Go deeper on CTR20130449.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20130449.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call